[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336955-105":59,"doc-detail-336955-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","plga-pei-nanoparticle-covered-with-polyic-for-personalised-cancer-immunotherapy","PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy","","Melanoma causes a large share of skin-cancer deaths, and traditional therapies often fail in advanced or metastatic disease. Although immunotherapy can be effective, response rates remain suboptimal. This work develops a personalized neoantigen peptide-based cancer vaccine by encapsulating patient-derived melanoma neoantigens in PEI-functionalised PLGA nanoparticles and coating them with poly(I:C). The modified nanoparticles stimulate dendritic cells and lymphocytes and show a superior immune activation profile versus formulations lacking poly(I:C) or antigen.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/plga-pei-nanoparticle-covered-with-polyic-for-personalised-cancer-immunotherapy/336955/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/plga-pei-nanoparticle-covered-with-polyic-for-personalised-cancer-immunotherapy/336955.png","ImageObject",300,407,{"name":92,"@type":93},"Skyler","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What vaccine platform is developed in this study?","Question",{"text":112,"@type":113},"Patient-derived melanoma neoantigen peptides are encapsulated in PEI-functionalised PLGA nanoparticles and coated with poly(I:C).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do the authors assess immune activation?",{"text":117,"@type":113},"They report that dendritic cells and lymphocytes are effectively stimulated, with an improved immune activation profile compared with nanoparticle formulations lacking poly(I:C) or antigen.",{"name":119,"@type":110,"acceptedAnswer":120},"Why are poly(I:C) coating and neoantigen loading important?",{"text":121,"@type":113},"The poly(I:C) acts as an immunoadjuvant while the encapsulated neoantigens provide the antigenic targets, resulting in an immune response optimized for melanoma tumor-cell elimination.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336955,1790218397,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Drug Delivery and Translational Research (2024) 14:2788–2803  \n[https://doi.org/10.1007/s13346-024-01557-2](https://doi.org/10.1007/s13346-024-01557-2)  \nPLGA‑PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy  \nLorena Gonzalez‑Melero1,2 · Edorta Santos‑Vizcaino1,2,3 · Ruben Varela‑Calvino4 · Iria Gomez‑Tourino5,6 · Aintzane Asumendi7,8 · Maria Dolores Boyano7,8 · Manoli Igartua1,2,3 · Rosa Maria Hernandez1,2,3  \nAccepted: 19 February 2024 / Published online: 1 March 2024 © The Author(s) 2024  \nAbstract  \nMelanoma is the main cause of death among skin cancers and its incidence worldwide has been experiencing an appalling increase. However, traditional treatments lack effectiveness in advanced or metastatic patients. Immunotherapy, meanwhile, has been shown to be an effective treatment option, but the rate of cancers responding remains far from ideal. Here we have developed a personalized neoantigen peptide-based cancer vaccine by encapsulating patient derived melanoma neoantigens in polyethylenimine (PEI)-functionalised poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) and coating them with polyinosinic:polycytidylicacid (poly(I:C)). We found that PLGA NPs can be effectively modified to be coated with the immunoadjuvant poly(I:C), as well as to encapsulate neoantigens. In addition, we found that both dendritic cells (DCs) and lymphocytes were effectively stimulated. Moreover, the developed NP was found to have a better immune activation profile than NP without poly(I:C) or without antigen. Our results demonstrate that the developed vaccine has a high capacity to activate the immune system, efficiently maturing DCs to present the antigen of choice and promoting the activity of lymphocytes to exert their cytotoxic function. Therefore, the immune response generated is optimal and specific for the elimination of melanoma tumour cells.  \nKeywords Cancer · Immunotherapy · Nanoparticle · Neoantigen · PLGA · Poly(I:C) · Vaccine  \nIntroduction  \nMelanoma is an aggressive type of skin cancer that originates in melanocytes, the cells that produce the pigment that gives colour to the skin. Although much less common  \nLorena Gonzalez-Melero and Edorta Santos-Vizcaino contributed equally to this work.  \n* Manoli Igartua[manoli.igartua@ehu.eus](manoli.igartua@ehu.eus)  \n* Rosa Maria Hernandez [rosa.hernandez@ehu.eus](rosa.hernandez@ehu.eus)  \n1 NanoBioCel Research Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain  \n2 Bioaraba, NanoBioCel Research Group, Vitoria-Gasteiz, Spain  \n3 Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Institute of Health Carlos III, Madrid, Spain  \n4 Department of Biochemistry and Molecular Biology, School of Pharmacy, University of Santiago de Compostela, Santiago, Spain  \nthan non-melanoma skin cancers, melanoma is the leading cause of death among them [1] . In general, the incidence of melanoma has experienced an alarming increase worldwide over the past several decades, particularly in regions with fair-skinned populations and high levels of exposure to ultraviolet (UV) radiation [1, 2] . Surgical excision has always been the primary treatment for melanoma [3] . However, not  \n5 Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, Santiago, Spain  \n6 Health Research Institute of Santiago de Compostela (IDIS), Santiago, Spain  \n7 Biocruces Bizkaia Health Research Institute,  \n48903 Barakaldo, Spain  \n8 Department of Cell Biology and Histology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain  \nall tumours are candidates for tumour resection. Fortunately, there has been a significant advance in the treatment of melanoma in recent years, which has changed the outcome of the disease [4] . Among them, immunotherapy has proven to be an effective treatment opti","cbCaibUos4yITKEA","https://ap.wps.com/l/cbCaibUos4yITKEA","pdf",8092148,16,"English","# Abstract\n# Introduction\n## Melanoma burden and limitations of conventional therapy\n## Immunotherapy: active vs passive approaches\n## Cancer vaccines and peptide-based strategies","[{\"question\":\"What vaccine platform is developed in this study?\",\"answer\":\"Patient-derived melanoma neoantigen peptides are encapsulated in PEI-functionalised PLGA nanoparticles and coated with poly(I:C).\"},{\"question\":\"How do the authors assess immune activation?\",\"answer\":\"They report that dendritic cells and lymphocytes are effectively stimulated, with an improved immune activation profile compared with nanoparticle formulations lacking poly(I:C) or antigen.\"},{\"question\":\"Why are poly(I:C) coating and neoantigen loading important?\",\"answer\":\"The poly(I:C) acts as an immunoadjuvant while the encapsulated neoantigens provide the antigenic targets, resulting in an immune response optimized for melanoma tumor-cell elimination.\"}]","PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy | PDF",1790017191,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f51de4ba967249db39afe56dadeb1bf4.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d7fb1b8467597561a79ab72f4f625e64.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/484e59ef27ab69501a391628c9b95b70.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/829ffc05a8161ed4b7f4deb1fc8d3bcc.webp",980,1301]